Market Currents
Qualitest Pharmaceuticals, a wholly-owned unit of Endo Pharmceuticals (ENDP) says the FDA has...
-
Monday, November 28, 2011, 6:42 PM ETQualitest Pharmaceuticals, a wholly-owned unit of Endo Pharmceuticals (ENDP) says the FDA has given the final approval for its Myzilra tablets. The total sales for Myzilra in the U.S. for the 12 months ending in September were approximately $34M.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
